Argentus Capital Management, LLC historic quarter change: Foreign Stocks, Added
In share positions in stocks (depositary receipts and foreign shares traded over the counter), over 13 quarters from 2013-06-30 to 2016-09-30, Argentus Capital Management, LLC opened 24 positions, added to 44, reduced 29 and sold out of 20.
- Q3 2016: Stock INFY; Country of operation —; Class SPONSORED ADR; Shares before 10,194.
- Q3 2016: Stock TEVA; Country of operation —; Class ADR; Shares before 6,110.
- Q3 2016: Stock SNY; Country of operation —; Class SPONSORED ADR; Shares before 13,338.
- Q3 2016: Stock DRD; Country of operation —; Class SPON ADR REPSTG; Shares before 10,964.
Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1476417), 13 quarters: Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-01); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-12); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-13); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-12); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-10); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-07-30); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-04); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-01-12); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-10-27); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-07-21); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-04-15); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-01-21); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-11-12). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2009-12-31.
| Quarter | Stock | Country of operation | Class | Shares before | Shares after | Share change | Value before | Value after | Value change | Filed |
|---|
| Q3 2016 | INFY
INFOSYS LTD | | SPONSORED ADR | 10,194 | 25,877 | +15,683 | $182,000 | $408,000 | +$226,000 | 2016-11-01 |
|---|
| Q3 2016 | TEVA
TEVA PHARMACEUTICAL INDS LTD | | ADR | 6,110 | 11,537 | +5,427 | $307,000 | $531,000 | +$224,000 | 2016-11-01 |
|---|
| Q3 2016 | SNY
SANOFI | | SPONSORED ADR | 13,338 | 13,673 | +335 | $558,000 | $522,000 | -$36,000 | 2016-11-01 |
|---|
| Q3 2016 | DRD
DRDGOLD LIMITED | | SPON ADR REPSTG | 10,964 | 12,932 | +1,968 | $65,000 | $64,000 | -$1,000 | 2016-11-01 |
|---|
| Q2 2016 | TEVA
TEVA PHARMACEUTICAL INDS LTD | | ADR | 2,702 | 6,110 | +3,408 | $145,000 | $307,000 | +$162,000 | 2016-08-12 |
|---|
| Q2 2016 | SNY
SANOFI | | SPONSORED ADR | 10,975 | 13,338 | +2,363 | $441,000 | $558,000 | +$117,000 | 2016-08-12 |
|---|
| Q2 2016 | INFY
INFOSYS LTD | | SPONSORED ADR | 3,492 | 10,194 | +6,702 | $66,000 | $182,000 | +$116,000 | 2016-08-12 |
|---|
| Q2 2016 | DEO
DIAGEO P L C | | SPON ADR NEW | 3,082 | 3,728 | +646 | $332,000 | $421,000 | +$89,000 | 2016-08-12 |
|---|
| Q1 2016 | SNY
SANOFI | | SPONSORED ADR | 7,724 | 10,975 | +3,251 | $329,000 | $441,000 | +$112,000 | 2016-05-13 |
|---|
| Q1 2016 | DEO
DIAGEO P L C | | SPON ADR NEW | 2,176 | 3,082 | +906 | $237,000 | $332,000 | +$95,000 | 2016-05-13 |
|---|
| Q1 2016 | BP
BP PLC | | SPONSORED ADR | 17,076 | 19,667 | +2,591 | $534,000 | $594,000 | +$60,000 | 2016-05-13 |
|---|
| Q1 2016 | TEVA
TEVA PHARMACEUTICAL INDS LTD | | ADR | 2,123 | 2,702 | +579 | $139,000 | $145,000 | +$6,000 | 2016-05-13 |
|---|
| Q3 2015 | BP
BP PLC | | SPONSORED ADR | 27,366 | 67,103 | +39,737 | $1,094,000 | $2,051,000 | +$957,000 | 2015-11-10 |
|---|
| Q3 2015 | TEVA
TEVA PHARMACEUTICAL INDS LTD | | ADR | 43,172 | 43,842 | +670 | $2,551,000 | $2,475,000 | -$76,000 | 2015-11-10 |
|---|
| Q2 2015 | INFY
* INFOSYS LTD | | SPONSORED ADR | 101,550 | 208,552 | +107,002 | $3,562,000 | $3,306,000 | -$256,000 | 2015-07-30 |
|---|
| Q2 2015 | INFY
* INFOSYS LTD SPONSORED | | ADR | 50,775 | 104,276 | +53,501 | $1,781,000 | $1,653,000 | -$128,000 | 2015-07-30 |
|---|
| Q2 2015 | SNY
* SANOFI | | SPONSORED ADR | 45,177 | 46,783 | +1,606 | $2,234,000 | $2,317,000 | +$83,000 | 2015-07-30 |
|---|
| Q2 2015 | SNY
* SANOFI SPONSORED | | ADR | 22,588 | 23,391 | +803 | $1,117,000 | $1,159,000 | +$42,000 | 2015-07-30 |
|---|
| Q2 2015 | TEVA
* TEVA PHARMACEUTICAL INDS LTD | | ADR | 41,441 | 43,172 | +1,731 | $2,582,000 | $2,551,000 | -$31,000 | 2015-07-30 |
|---|
| Q1 2015 | SNY
* SANOFI | | SPONSORED ADR | 35,074 | 45,177 | +10,103 | $1,600,000 | $2,234,000 | +$634,000 | 2015-05-04 |
|---|
| Q1 2015 | INFY
* INFOSYS LTD | | SPONSORED ADR | 98,514 | 101,550 | +3,036 | $3,099,000 | $3,562,000 | +$463,000 | 2015-05-04 |
|---|
| Q1 2015 | SNY
* SANOFI SPONSORED | | ADR | 17,537 | 22,588 | +5,051 | $800,000 | $1,117,000 | +$317,000 | 2015-05-04 |
|---|
| Q1 2015 | TEVA
* TEVA PHARMACEUTICAL INDS LTD | | ADR | 40,025 | 41,441 | +1,416 | $2,302,000 | $2,582,000 | +$280,000 | 2015-05-04 |
|---|
| Q1 2015 | INFY
* INFOSYS LTD SPONSORED | | ADR | 49,257 | 50,775 | +1,518 | $1,550,000 | $1,781,000 | +$231,000 | 2015-05-04 |
|---|
| Q4 2014 | INFY
* INFOSYS LTD | | SPONSORED ADR | 45,806 | 98,514 | +52,708 | $2,771,000 | $3,099,000 | +$328,000 | 2015-01-12 |
|---|
| Q4 2014 | INFY
* INFOSYS LTD SPONSORED | | ADR | 22,903 | 49,257 | +26,354 | $1,385,000 | $1,550,000 | +$165,000 | 2015-01-12 |
|---|
| Q3 2014 | BP
* BP PLC | | SPONSORED ADR | 19,162 | 35,004 | +15,842 | $1,011,000 | $1,538,000 | +$527,000 | 2014-10-27 |
|---|
| Q3 2014 | INFY
* INFOSYS LTD | | SPONSORED ADR | 45,036 | 45,806 | +770 | $2,422,000 | $2,771,000 | +$349,000 | 2014-10-27 |
|---|
| Q3 2014 | INFY
* INFOSYS LTD SPONSORED | | ADR | 22,518 | 22,903 | +385 | $1,211,000 | $1,385,000 | +$174,000 | 2014-10-27 |
|---|
| Q3 2014 | TEVA
* TEVA PHARMACEUTICAL INDS LTD | | ADR | 40,907 | 41,001 | +94 | $2,144,000 | $2,204,000 | +$60,000 | 2014-10-27 |
|---|
| Q2 2014 | BP
* BP PLC | | SPONSORED ADR | 14,794 | 19,162 | +4,368 | $712,000 | $1,011,000 | +$299,000 | 2014-07-21 |
|---|
| Q2 2014 | INFY
* INFOSYS LTD | | SPONSORED ADR | 42,030 | 45,036 | +3,006 | $2,277,000 | $2,422,000 | +$145,000 | 2014-07-21 |
|---|
| Q2 2014 | INFY
* INFOSYS LTD SPONSORED | | ADR | 21,015 | 22,518 | +1,503 | $1,139,000 | $1,211,000 | +$72,000 | 2014-07-21 |
|---|
| Q1 2014 | TEVA
* TEVA PHARMACEUTICAL INDS LTD | | ADR | 40,077 | 42,264 | +2,187 | $1,606,000 | $2,233,000 | +$627,000 | 2014-04-15 |
|---|
| Q1 2014 | BP
* BP PLC | | SPONSORED ADR | 13,086 | 14,794 | +1,708 | $636,000 | $712,000 | +$76,000 | 2014-04-15 |
|---|
| Q1 2014 | INFY
* INFOSYS LTD | | SPONSORED ADR | 39,296 | 42,030 | +2,734 | $2,224,000 | $2,277,000 | +$53,000 | 2014-04-15 |
|---|
| Q1 2014 | INFY
* INFOSYS LTD SPONSORED | | ADR | 19,648 | 21,015 | +1,367 | $1,112,000 | $1,139,000 | +$27,000 | 2014-04-15 |
|---|
| Q4 2013 | INFY
* INFOSYS LTD | | SPONSORED ADR | 34,156 | 39,296 | +5,140 | $1,643,000 | $2,224,000 | +$581,000 | 2014-01-21 |
|---|
| Q4 2013 | INFY
* INFOSYS LTD SPONSORED | | ADR | 17,078 | 19,648 | +2,570 | $822,000 | $1,112,000 | +$290,000 | 2014-01-21 |
|---|
| Q4 2013 | TEVA
* TEVA PHARMACEUTICAL INDS LTD | | ADR | 38,969 | 40,077 | +1,108 | $1,472,000 | $1,606,000 | +$134,000 | 2014-01-21 |
|---|
| Q3 2013 | YPF
* YPF SOCIEDAD ANONIMA | | SPON ADR CL D | 18,870 | 31,575 | +12,705 | $279,000 | $636,000 | +$357,000 | 2013-11-12 |
|---|
| Q3 2013 | PBR
* PETROLEO BRASILEIRO SA PETRO | | SPONSORED ADR | 11,000 | 24,005 | +13,005 | $148,000 | $372,000 | +$224,000 | 2013-11-12 |
|---|
| Q3 2013 | TEVA
* TEVA PHARMACEUTICAL INDS LTD | | ADR | 36,241 | 38,969 | +2,728 | $1,421,000 | $1,472,000 | +$51,000 | 2013-11-12 |
|---|
| Q3 2013 | PBR
* PETROLEO BRASILEIRO SA PETRO SPONSORED | | ADR | 11,000 | 12,002 | +1,002 | $148,000 | $186,000 | +$38,000 | 2013-11-12 |
|---|
Similar Firms
| Firm Name | Country | 13F Value | Holdings |
|---|
| Not available yet |